Correlation of MMP-3 and MMP-9 with Crohn's Disease Activity in Children

被引:43
|
作者
Kofla-Dlubacz, Anna [2 ,3 ]
Matusiewicz, Malgorzata [1 ]
Krzystek-Korpacka, Malgorzata [1 ]
Iwanczak, Barbara [2 ,3 ]
机构
[1] Wroclaw Med Univ, Dept Med Biochem, PL-50358 Wroclaw, Poland
[2] Wroclaw Med Univ, Clin Paediat Gastroenterol & Nutr, PL-50358 Wroclaw, Poland
[3] Wroclaw Med Univ, Dept 2, PL-50358 Wroclaw, Poland
关键词
Inflammatory bowel disease; Crohn's disease; Children; Metalloproteinases; PCDAI; INFLAMMATORY-BOWEL-DISEASE; MATRIX METALLOPROTEINASES; INTESTINAL INJURY; TISSUE INHIBITORS; RAT MODEL; EXPRESSION; MATRIX-METALLOPROTEINASE-9; COLITIS; MARKERS; MUCOSA;
D O I
10.1007/s10620-011-1936-z
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Recently published data indicate that the inflammation in Crohn's disease (CD) may be accompanied by elevated levels of matrix metalloproteinases. The goals of the present study were the estimation of MMP-3 and -9 concentrations in sera of children with Crohn's disease, the examination of correlation between the concentrations of MMP-3 and -9 and clinical activity of the disease in the relation to the control group and the evaluation of the utility of MMP-3 and -9 concentration measurements as markers of disease activity. Serum concentrations of MMP-3 and -9 were estimated in 82 children (45 CD patients divided into severe, moderate and mild subgroups; 37 controls) and correlated with disease activity estimated by the Pediatric Crohn's Disease Activity Index (PCDAI), CRP, seromucoid and ESR. Mean MMP-3 concentrations were: 2.49 ng/ml (95% CI: 1.76-3.52) for mild, 16.44 ng/ml (95% CI: 10.34-26.15) for moderate, 5.25 ng/ml (95% CI: 2.73-10.11) for severe CD and 1.95 ng/ml (95% CI: 1.53-2.48) for the control group (differences between all three groups were statistically significant; P < 0.001). Median MMP-9 concentrations were: 2.14 ng/ml (95% CI: 0-8.9) for mild, 14.21 ng/ml (95% CI: 4.53-21.48) for moderate, 42.2 ng/ml (95% CI: 5.74-61.27) for severe CD and 1.3 ng/ml (95% CI: 0.7-2.18) for the control group. MMP-9 concentrations in moderate and severe CD differed from the concentrations in mild CD (P = 0.002) and control group (P = 0.0001). MMP-3 concentration significantly correlated with MMP-9, PCDAI and ESR, while MMP-9 concentration significantly positively correlated with MMP-3, PCDAI, and CRP. Diagnostic utilities of the tests were: MMP-3 accuracy 75%, positive likelihood ratio (LR+) = 4.11 and negative likelihood ratio (LR-) = 0.51, sensitivity 56%, specificity 87%, Youden index 0.43; for MMP-9, accuracy 73%, LR+ = 5.14 and LR- = 0.50, sensitivity 56%, specificity 89%, Youden index 0.45; and for CRP, accuracy 74%, LR+ = 8.56 and LR- = 0.54, sensitivity 49%, specificity 94%, Youden index 0.43. MMP-9 serum concentration increasing along with the activity of the disease, exhibiting high specificity and correlating well with the indices of inflammation might be of better usefulness in the prediction of CD activity status in children than MMP-3.
引用
收藏
页码:706 / 712
页数:7
相关论文
共 50 条
  • [1] Correlation of MMP-3 and MMP-9 with Crohn’s Disease Activity in Children
    Anna Kofla-Dlubacz
    Malgorzata Matusiewicz
    Malgorzata Krzystek-Korpacka
    Barbara Iwanczak
    Digestive Diseases and Sciences, 2012, 57 : 706 - 712
  • [2] Association between MMP-3 and MMP-9 polymorphisms and coronary artery disease
    Beton, Osman
    Arslan, Serdal
    Acar, Burak
    Ozbilum, Nil
    Berkan, Ocal
    BIOMEDICAL REPORTS, 2016, 5 (06) : 709 - 714
  • [3] MMP-3, MMP-7, MMP-9 expression in endometrial carcinoma
    Xiong, JJ
    Mercurio, JW
    Sheehan, CE
    Petrocine, S
    Ambros, RA
    Ross, JS
    MODERN PATHOLOGY, 2003, 16 (01) : 214A - 215A
  • [4] MMP-3, MMP-7, MMP-9 expression in endometrial carcinoma
    Xiong, JJ
    Mercurio, JW
    Sheehan, CE
    Petrocine, S
    Ambros, RA
    Ross, JS
    LABORATORY INVESTIGATION, 2003, 83 (01) : 214A - 215A
  • [5] Correlations of MMP-3 and MMP-9 gene polymorphisms with diabetic retinopathy
    Wei, Shufang
    Wu, Qizheng
    Gao, Hongxia
    Pei, Caiying
    PANMINERVA MEDICA, 2021, 63 (02) : 239 - 240
  • [6] Matrix metalloproteinases (MMP-3 and MMP-9) implication in the pathogenesis of inflammatory bowel disease (IBD)
    Silosi, Isabela
    Boldeanu, Mihai Virgil
    Mogoanta, Stelian Stefanita
    Ghilusi, Mirela
    Cojocaru, Manole
    Biciusca, Viorel
    Cojocaru, Inimioara Mihaela
    Avramescu, Carmen Silvia
    Gheonea, Dan Ionut
    Silosi, Cristian Adrian
    Turculeanu, Adriana
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2014, 55 (04): : 1317 - 1324
  • [7] The association of MMP-1, MMP-3 and MMP-9 genotypes with prognosis of hepatocellular carcinoma
    Okamoto, K
    Mimura, K
    Murawaki, Y
    Yuasa, I
    JOURNAL OF HEPATOLOGY, 2004, 40 : 81 - 81
  • [8] MMP-3 and MMP-9 predicts mortality in acute decompensated heart failure
    Mohammed, N.
    Narayan, H.
    Squire, I.
    Ng, L.
    EUROPEAN HEART JOURNAL, 2014, 35 : 1194 - 1194
  • [9] Genetic association between matrix metalloproteinase MMP-9 and MMP-3 polymorphisms and Japanese sporadic Alzheimer's disease
    Shibata, N
    Ohnuma, T
    Higashi, S
    Usui, C
    Ohkubo, T
    Kitajima, A
    Ueki, A
    Nagao, M
    Arai, H
    NEUROBIOLOGY OF AGING, 2005, 26 (07) : 1011 - 1014
  • [10] MMP-9 and MMP-3 gene polymorphisms in neonatal hypoxic ischemic encephalopathy
    Li, Hongshuang
    Yang, Min
    Zhao, Zhihong
    Zhou, Xiaojuan
    Liu, Yingchao
    Zhuang, Yuanhua
    Shan, Yufeng
    JOURNAL OF NEUROSURGICAL SCIENCES, 2020, 64 (06) : 579 - 581